Racura Oncology Ltd

A$1.48As of Sun 8 Nov 2026, 12:00 UTC
ASX:RACHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 19.14%
Div yield —
ROE (42.28%)
Biotechnology
Beta (5Y) 0.96
PE TTM —
TSR TTM (56.62%)
Mkt cap A$289.2M
ROIC (24.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.91
29.63%
108.73%
Hold 10|4|11|0|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.02
0.02
10.30%
14.79%
9.12%
12.13%
Revenue$M
19.03
18.59
18.98
19.77
6.05%
4.41%
1.85%
4.76%
Peers (US$198.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.684
0.032
0.028
EBIT/Intx
1.488
0.178
0.166
Own earn%
(66.04)
(153.70)
(156.92)
Sh yield%
51.70
20.17
20.50
Owners
Insiders/Inst%
0.49
50.93
Short interest%
5.29
SBC / revenue%
3.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–3
$1 testx
−0.2
Incr. ROIC%
9